Global Arterial Cannula Market Size, Share, and COVID-19 Impact Analysis, By Size (14-16 Fr, 17-19 Fr, 20-22 Fr, 23-25 Fr, 26-28 Fr, 29-31 Fr, 32-34 Fr, and 35-36 Fr), By Application (Extracorporeal Membrane Oxygenation (ECMO), Cardiopulmonary Bypass Surgery, and Others), By End-Use (Hospitals, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035.

Global Arterial Cannula Market Insights Forecasts to 2035

• The Global Arterial Cannula Market Size Was Estimated at USD 21.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.35% from 2025 to 2035
• The Worldwide Arterial Cannula Market Size is Expected to Reach USD 46.9 Million by 2035
• Asia Pacific is expected to Grow the fastest during the forecast period.

The Global Arterial Cannula Market Size was worth around USD 21.5 Million in 2024 and is predicted to Grow to around USD 46.9 Million by 2035 with a compound annual growth rate (CAGR) of 7.35% from 2025 to 2035. The growing prevalence of chronic diseases, including cardiovascular disorders, advanced healthcare infrastructure, and adoption of minimally invasive surgical procedures, are driving the arterial cannula market globally.

Market Overview

The arterial cannula market refers to the industry emphasizing the manufacturing, distribution, and sale of arterial cannulas, which are thin, flexible tubes used for accessing and monitoring a patient’s arterial system. An arterial cannula is used in a process performed in acute and critical care settings, serving as an invasive means to more accurately measure blood pressure and arterial pressure than non-invasive means. There is an increasing demand for arterial cannula due to the chronic conditions requiring procedures like cardiopulmonary bypass surgery (CABG), dialysis, and ECMO (Extracorporeal Membrane Oxygenation).

The introduction of machine learning and artificial intelligence enables effective data-driven decision-making in the market. Further, the increasing integration of AI-based systems for precise management of cardiovascular disorders, including atrial fibrillation and coronary artery disease (CAD), is escalating the market growth opportunities. 

Report Coverage

This research report categorizes the arterial cannula market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the arterial cannula market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the arterial cannula market.

Driving Factors

The growing prevalence of chronic diseases, including cardiovascular disorders, diabetes, stroke, and cancer contributing to driving the market demand for arterial cannula, as it is importantly used for managing diseases for continuous monitoring (including hemodynamic monitoring) and frequent blood sampling. The creation of innovative, biocompatible cannula materials along with the advancement in minimally invasive surgeries is propelling the market growth for arterial cannula. Further, the advanced healthcare infrastructure, as well as increasing use of respiratory & cardiac support in critical care settings, is promoting the market growth for arterial cannula.

Restraining Factors

An increased cost of cardiac treatment and surgery, stringent regulations, potential risks, and complications associated with the use of arterial cannula are challenging the arterial cannula market. Further, the lack of decentralization of cardiac surgical procedures is negatively affecting the market growth.

Market Segmentation

The arterial cannula market share is classified into size, application, and end-use.

• The 20-22 Fr segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the size, the arterial cannula market is divided into 14-16 Fr, 17-19 Fr, 20-22 Fr, 23-25 Fr, 26-28 Fr, 29-31 Fr, 32-34 Fr, and 35-36 Fr. Among these, the 20-22 Fr segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. A 20-22 Fr size arterial cannula is mainly used in cardiac surgeries and ECMO applications owing to its compatibility with adult arterial anatomy. An increasing adoption of 20-22 Fr size arterial cannula for ECMO procedures, with a sudden rise in demand during the pandemic contributing to propel the market growth.

• The extracorporeal membrane oxygenation (ECMO) segment dominated the market with the maximum share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the application, the arterial cannula market is divided into extracorporeal membrane oxygenation (ECMO), cardiopulmonary bypass surgery, and others. Among these, the extracorporeal membrane oxygenation (ECMO) segment dominated the market with the maximum share in 2024 and is projected to grow at a substantial CAGR during the forecast period. It was estimated that around 37 million Americans live with chronic lung disease, including bronchitis and emphysema. An increasing prevalence of cardiac surgeries, as well as lung diseases and ECMO, is contributing to driving the market demand for arterial cannula.

• The hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end-use, the arterial cannula market is divided into hospitals, ambulatory surgical centers, and others. Among these, the hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Hospitals are a crucial part of the healthcare industry, fueling research and innovation in the field. Further, various healthcare product manufacturers invest prominently to promote their products and services among hospitals. An increasing number of surgeries, as well as the presence of a skilled workforce in hospital settings, are responsible for promoting the arterial cannula market.

Regional Segment Analysis of the Arterial Cannula Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the arterial cannula market over the predicted timeframe.

North America is anticipated to hold the largest share of the arterial cannula market over the predicted timeframe. The growing prevalence of chronic diseases, along with the presence of advanced healthcare infrastructure in the region, is responsible for driving the market for arterial cannula. An increasing number of surgical procedures, driving the demand for arterial cannula for blood pressure monitoring, blood sampling, or administration of medications, is propelling the market. Technological advancements for improved arterial cannula designs and applications in order to enhance patient safety and clinical outcomes drive the market growth.

Asia Pacific is expected to grow at a rapid CAGR in the arterial cannula market during the forecast period. The growing prevalence of cardiovascular diseases and an aging population are contributing to driving the market demand for arterial cannula. Further, the presence of improved healthcare infrastructure with increased accessibility of advanced medical technologies and emphasis on minimally invasive procedures significantly contributes to propelling the market growth.

Europe is anticipated to hold a substantial share of the arterial cannula market during the projected timeframe. The growing regional elderly population is driving the demand for cardiovascular interventions, which is propelling the arterial cannula market demand. Further, an increasing number of surgical procedures, healthcare establishments, and R&D investments by government and non-government organizations are contributing to propelling the market in the region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the arterial cannula market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medtronic, plc.
• LivaNova plc
• Edward Lifesciences
• Getinge AB
• Fresenius Medical Care
• BD
• Nipro Corp.
• Andocor
• Freelife Medical GmbH
• Surgical Holdings
• Kangxin Medical
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In September 2024, Shockwave Medical Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, announced the full U.S. launch of the Shockwave E8 Peripheral IVL Catheter, following clearance by the U.S. Food and Drug administration (FDA).

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the arterial cannula market based on the below-mentioned segments: 

Global Arterial Cannula Market, By Size

• 14-16 Fr
• 17-19 Fr
• 20-22 Fr
• 23-25 Fr
• 26-28 Fr
• 29-31 Fr
• 32-34 Fr
• 35-36 Fr

Global Arterial Cannula Market, By Application

• Extracorporeal Membrane Oxygenation (ECMO)
• Cardiopulmonary Bypass Surgery
• Others

Global Arterial Cannula Market, By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Arterial Cannula Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa